- Phone: 215-525-8695
- Location: 1233 Locust St, 5th floor, Philadelphia PA 19107
Philadelphia FIGHT (FIGHT) was founded as the Community-Based Research Initiative on AIDS as a partnership of individuals living with HIV/AIDS and clinicians who joined together to improve the lives of people living with the disease by testing potential treatments for HIV/AIDS and its complications. Today, clinicians at FIGHT continue to be involved in a number of studies.
What is a clinical trial?
A clinical trial is a controlled experiment in which people take medication for a specified time to determine its effectiveness and safety. Information gathered from clinical trials help create future treatments. Clinical trials are currently the most effective way to help people who have exhausted all proven therapies and to develop new and better treatments for people living with HIV/AIDS.
Who can enroll in a trial?
Each clinical trial has specific requirements; anyone meeting those requirements may be eligible to enroll in a trial. FIGHT clinical trials are free and participation is voluntary. Before participating in a study, patients go through a consenting process, which explains all the risks and benefits of that particular study. Participants may withdraw from clinical trials at any time without affecting access to their health care.
Click the link to view ongoing trials conducted at Philadelphia FIGHT Community Health Centers.
If you are interested in participating in clinical trials, please contact the research staff of Philadelphia FIGHT at 215-525-8695.
What’s new in FIGHT Research?
New PreEP Study
The Philadelphia FIGHT Research Department is proud to announce our participation in the DISCOVER (GS-US-412-2055) Trial, a randomized and double-blind clinical trial evaluating the safety and efficacy of Tenofovir Alafenamide for PrEP (pre-exposure prophylaxis). If you or someone you know is considering taking PrEP, please call the Research Department at 215-525-8695 for more information or to see if you might qualify. Please also see our ongoing trials for more information about the trials currently enrolling at Philadelphia FIGHT.
Linden Lalley-Chareczko, MA, Research Coordinator and Helen Koenig, MD, MPH, had the honor of presenting original research at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, Washington. A study designed by Helen Koenig, MD, MPH and conducted at YHEP Health Center provided meaningful information on the ability of young MSM and TGW to adhere to oral Truvada for PrEP through the use of a urine test conceptualized by Dr. Koenig. This research represents the first evaluation of an objective, non-invasive measure of PrEP adherence designed for in-clinic use. Furthermore, this research provides strong evidence supporting the idea that young adults can maintain protective drug levels over time with adequate support from care providers and clinic staff.